Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Hepatology

• Publication date

  1990-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 2204661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anticatabolic Effect of Branched‐Chain Amino Acid‐Enriched Solutions in Patients with Liver Cirrhosis

  2007cited by this paper
• Effects of chronic oral branched-chain amino acid supplementation in a subpopulation of cirrhotics.

  1990cited by this paper
• The usefulness of branched chain amino acids in patients with acute or chronic hepatic encephalopathy.

  1989cited by this paper
• Branched‐chain amino acids in the management of hepatic encephalopathy: An analysis of variants

  1989cited by this paper
• Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis.

  1989cited by this paper
• Effects of dietary protein intake on branched-chain keto acid dehydrogenase activity of the rat. Immunochemical analysis of the enzyme complex.

  1988cited by this paper
• Parenteral nutrition in patients with liver disease.

  1988cited by this paper
• Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies.

  1988cited by this paper
• Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis.

  1987cited by this paper
• Activation of branched-chain alpha-ketoacid dehydrogenase in isolated hepatocytes by branched-chain alpha-ketoacids.

  1987cited by this paper
• Serum thyroid hormone, triiodothyronine, thyroxine, and triiodothyronine/thyroxine ratio in patients with fulminant, acute, and chronic hepatitis.

  1986cited by this paper
• Postoperative parenteral nutrition with high supply of branched-chain amino acids: effects on nitrogen balance and liver protein synthesis.

  1986cited by this paper
• The use of branched chain amino acids (BCAA) in acute hepatic encephalopathy.

  1986cited by this paper
• Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study.

  1985cited by this paper
• Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy.

  1984cited by this paper
• Comparison of Dietary Protein with an Oral, Branched Chain‐Enriched Amino Acid Supplement in Chronic Portal‐Systemic Encephalopathy: A Randomized Controlled Trial

  1984cited by this paper
• Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy.

  1984cited by this paper
• Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis.

  1984cited by this paper
• High-branched chain amino acid solutions: relationship of composition to efficacy.

  1984cited by this paper
• Therapeutic aspects of branched-chain amino and keto acids.

  1984cited by this paper
• Thyroid function in nonthyroidal illnesses.

  1983cited by this paper
• Plasma amino acid response to protein ingestion in patients with liver cirrhosis.

  1983cited by this paper
• Comparison of the Effects of Hepatic‐Aid and a Casein Modular Diet on Enceph‐alopathy, Plasma Amino Acids, and Nitrogen Balance in Cirrhotic Patients

  1983cited by this paper
• Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.

  1982cited by this paper
• Infusion of Branched‐chain Enriched Amino Acid Solution in: Patients with Hepatic Encephalopathy

  1982cited by this paper
• Enteral hyperalimentation in undernourished patients with cirrhosis and ascites.

  1982cited by this paper
• Muscle protein breakdown in liver cirrhosis and the role of altered carbohydrate metabolism

  1981cited by this paper
• Negative nitrogen balance in cirrhotics. (A correct therapeutic approach).

  1981cited by this paper
• Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity.

  1981cited by this paper
• Latent portasystemic encephalopathy

  1981cited by this paper
• Malnutrition and immuno-incompetence in patients with liver disease.

  1980cited by this paper
• Quantitative importance of non-skeletal-muscle sources of N tau-methylhistidine in urine.

  1980cited by this paper
• Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance

  1980cited by this paper
• Serum thyroid hormone levels in patients with liver disease.

  1979cited by this paper
• Tryptophan and hepatic coma.

  1978cited by this paper
• The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

  1978cited by this paper
• Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

  1977cited by this paper
• The effect of normalization of plasma amino acids on hepatic encephalopathy in man.

  1976cited by this paper
• Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

  1975cited by this paper
• Uptake of ammonia by muscle; its implications in ammoniagenic coma.

  1955cited by this paper

• Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.

  2026cites this paper
• Association of the protein-sodium dietary index with the incidence of clinical decompensation in patients with liver cirrhosis.

  2025cites this paper
• Intravenous branched-chain amino acid administration for the acute treatment of hepatic encephalopathy: a systematic review and meta-analysis

  2025cites this paper
• Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review.

  2025cites this paper
• Future Therapies of Hepatic Encephalopathy.

  2024cites this paper
• Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease

  2023cites this paper
• [ESPEN Practical Guideline: Clinical nutrition in liver disease].

  2022cites this paper
• Favorable and harmful effects of branched-chain amino acid administration in patients with liver cirrhosis: effects on hepatic encephalopathy and ammonia metabolism

  2022cites this paper
• Effect of long-term aggressive nutrition therapy on survival in patients with alcohol-related cirrhosis: A randomized controlled trial

  2022cites this paper
• Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.

  2022cites this paper
• The impact of branched-chain amino acid supplementation on measures of glucose homeostasis in individuals with hepatic disorders: A systematic review of clinical studies.

  2022cites this paper
• Branched-chain amino acids supplementation has beneficial effects on the progression of liver cirrhosis: A meta-analysis

  2022cites this paper
• Ammonia Removal by Metabolic Scavengers for the Prevention and Treatment of Hepatic Encephalopathy in Cirrhosis

  2021cites this paper
• Dietary nutrition for neurological disease therapy: Current status and future directions.

  2021cites this paper
• Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

  2021cites this paper
• Impact of Branched Chain Amino Acid on Muscle Mass, Muscle Strength, Physical Performance, Combined Survival, and Maintenance of Liver Function Changes in Laboratory and Prognostic Markers on Sarcopenic Patients With Liver Cirrhosis (BCAAS Study): A Randomized Clinical Trial

  2021cites this paper
• A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy

  2021cites this paper
• Protective effects of synbiotic soymilk fortified with whey protein concentrate and zinc sulfate against bile duct ligated-induced hepatic encephalopathy

  2020cites this paper
• Branched-chain amino acid supplementation ameliorates angiotensin II-induced skeletal muscle atrophy.

  2020cites this paper
• ESPEN practical guideline: Clinical nutrition in liver disease.

  2020cites this paper
• Serum γ-globulin and albumin concentrations predict secondary loss of response to anti-TNFα in inflammatory bowel disease patients.

  2019cites this paper
• ESPEN guideline on clinical nutrition in liver disease.

  2019cites this paper
• Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease

  2019cites this paper
• Splenectomy Leads to Amelioration of Altered Gut Microbiota and Metabolome in Liver Cirrhosis Patients

  2018cites this paper
• Effect of oral branched chain amino acids enriched snack in the cirrhotic patient with sleep disturbance

  2018cites this paper
• Hepatic Encephalopathy

  2018cites this paper
• Is the Response of Tumours Dependent on the Dietary Input of Some Amino Acids or Ratios among Essential and Non-Essential Amino Acids? All That Glitters Is Not Gold

  2018cites this paper
• Is the Response of Tumours Dependent on Dietary Input of Some Amino Acids or on the Ratios Among Essential and Non-Essential Amino Acids? All That Glisters is Not Gold

  2018cites this paper
• Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review.

  2018cites this paper
• KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

  2018cites this paper
• Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation.

  2017cites this paper
• Pathophysiology and Management of Alcoholic Liver Disease: Update 2016

  2017cites this paper
• Nutrition and the transplant candidate

  2017cites this paper
• COMPARISON OF RIFAXIMIN, LACTULOSE WITH RIFAXIMIN, LACTULOSE, BRANCHED CHAIN AMINOACIDS (BCAA) IN GRADE 1 TO GRADE 3 OF HEPATIC ENCEPHALOPATHY- NON RANDOMIZED CONTROLLED TRIAL STUDY

  2017cites this paper
• Branched-chain amino acids for people with hepatic encephalopathy.

  2017cites this paper
• Targeting the muscle for the treatment and prevention of hepatic encephalopathy.

  2016cites this paper
• Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements

  2016cites this paper
• Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?

  2016cites this paper
• A Randomized Clinical Trial of Preoperative Administration of Branched-Chain Amino Acids to Prevent Postoperative Ascites in Patients with Liver Resection for Hepatocellular Carcinoma

  2016cites this paper
• Pharmacotherapy of alcoholic liver disease in clinical practice

  2016cites this paper
• Advances in alcoholic liver disease: An update on alcoholic hepatitis.

  2015cites this paper
• Branched-chain amino acids for people with hepatic encephalopathy.

  2015cites this paper
• Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.

  2015cites this paper
• Recent advances in the treatment of hyperammonemia.

  2015cites this paper
• How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist

  2015cites this paper
• Pathophysiology and management of hepatic encephalopathy 2014 update: Ammonia toxicity and hyponatremia

  2015cites this paper
• Systematic review with network meta‐analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy

  2015cites this paper
• Protein Recommendations for Older Adults with Cirrhosis: A Review

  2015cites this paper
• Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis.

  2014cites this paper
• Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review.

  2014cites this paper
• Pathophysiology, diagnosis, and management of hepatic encephalopathy

  2014cites this paper
• [Nutritional care for patients with liver cirrhosis].

  2014cites this paper
• Alcoholic liver disease: treatment.

  2014cites this paper
• Oral supplementation with branched‐chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C‐related cirrhosis: A propensity score analysis

  2014cites this paper
• Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view

  2014cites this paper
• Adjuvant Therapy for Hepatocellular Carcinoma after Curative Treatment

  2014cites this paper
• Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.

  2013influential citation
• KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease

  2013cites this paper
• Handbook of nutrition, diet and sleep

  2013cites this paper
• Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.

  2013cites this paper
• Branched-chain amino acids and muscle ammonia detoxification in cirrhosis

  2013cites this paper
• The Effect of Long-term Supplementation With Branched-chain Amino Acid Granules in Patients With Hepatitis C Virus-related Hepatocellular Carcinoma After Radiofrequency Thermal Ablation

  2013cites this paper
• 24 Hepatic Encephalopathy

  2012cites this paper
• Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.

  2012cites this paper
• Biochemical changes in Alcoholics - A case control study

  2012cites this paper
• Nutritional support for liver disease.

  2012cites this paper
• Integrated Healthcare Practitioners ’ Dietary and Nutritional Supplement , and Herbal Remedies Management Program

  2012cites this paper
• Consilience in sarcopenia of cirrhosis

  2012cites this paper
• Ammonia‐Lowering Strategies for the Treatment of Hepatic Encephalopathy

  2012cites this paper
• Response to Mumtaz and Ford

  2011cites this paper
• Prognostic Impact of Preoperative the Branched-Chain Amino Acid to the Tyrosine Ratio in Hepatocellular Carcinoma Patients after Initial Hepatectomy

  2011cites this paper
• Amino acids and psychiatric disorders : a historical background

  2011cites this paper
• An overview of the therapeutic effects of leucine supplementation on skeletal muscle under atrophic conditions

  2011cites this paper
• Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects.

  2011cites this paper
• Is the Lymphoma Risk Reduced in Viral Hepatitis? A Cirrhotic Patient With Triple Malignancies

  2011cites this paper
• Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy.

  2011cites this paper
• Low-protein diets for hepatic encephalopathy debunked: let them eat steak.

  2011cites this paper
• Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes.

  2011cites this paper
• The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.

  2011cites this paper
• Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

  2011cites this paper
• Alcoholic liver disease

  2010cites this paper
• Effect of an oral branched chain amino acid‐enriched snack in cirrhotic patients with sleep disturbance

  2010cites this paper
• Nutrition support in end-stage liver disease.

  2010cites this paper
• Nutrition in hepatic encephalopathy.

  2010cites this paper
• Pathogenesis and management of alcoholic liver cirrhosis: a review

  2010cites this paper
• The Efficacy of L-Ornithine L-Aspartate Granules and Normal Protein Diet in Minimal Hepatic Encephalopathy with Malnutrition

  2010cites this paper
• Pharmacotherapy for Hepatic Encephalopathy

  2010cites this paper
• AASLD PRACTICE GUIDELINES Alcoholic Liver Disease

  2009cites this paper
• Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure

  2009cites this paper
• A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.

  2009cites this paper
• Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study

  2009cites this paper
• [Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support].

  2008cites this paper
• Role of branched‐chain amino acids in management of cirrhosis and hepatocellular carcinoma

  2008cites this paper
• Nutrition in end-stage liver disease: principles and practice.

  2008cites this paper
• Hepatic Encephalopathy

  2008cites this paper
• The role of nutrition in hepatic encephalopathy

  2008cites this paper
• [Nutrition in chronic liver diseases].

  2008cites this paper
• Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C?

  2008cites this paper
• Role of branched-chain amino acids in liver disease: the evidence for and against

  2007cites this paper
• Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis

  2007cites this paper